-
Price Momentum
NVAX is trading in the middle of its 52-week range and above its 200-day simple moving average.
-
Price change
The price of NVAX shares has decreased $0.37 since the market last closed. This is a 3.89% drop.
-
Closed at $9.13.
The stock has since dropped $0.01 in after-hours trading.
Key terms
About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
-
Market cap: $1.50B
A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.
Key terms
Smart score
Latest NVAX news
NVAX Financials
-
Total revenue: $1.12B (1Y), $139.51M (Q1)
Total Revenue increased 64.69% since last year and decreased 5.18% since last quarter.
-
Net income: $440.30M (1Y), -$9.49M (Q1)
Net Income increased 334.83% since last year and decreased 154.15% since last quarter.
-
Earnings per share: $2.54 (1Y), -$0.06 (Q1)
EPS increased 306.46% since last year and decreased 154.76% since last quarter.
Key terms
NVAX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVAX Competitors
-
How competitors are chosen
NVAX's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.50B
A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.





